Member Info for Newuncle

Looks like everyone is sitting on their hands now and waiting for the seller to clear.

Sub £4m Mcap but little sign the seller is done here and no one wants to catch that falling knife yet.

Ok, lets just keep it simple, current MCAP is £17m, is that cheap, fair value or over priced and why?

Stuart is 100% correct there

Rob,

Me too and others as well. If you are not part of the happy clappy millionaires gang of groupies there it offers nothing.

Now I can see that's being played out here too.

Not allowed to question anything or anyone's assumptions of the enormous riches to come here.

Just have to wait for the bank of PPP cashpoint to open and start spewing out £50 notes for everyone.

No it isn't becoming tedious

It is tedious, very, very tedious...LSE board is being turned into a carbon copy of the telegram group

Nothing ventured, Nothing gained as they say, at least you know the risks and can quantify them to some extent v the opportunity.

For me, the upside is going to take a little longer than current MCAP supports.

A question and question mark related to OBD's ability to justify their £18 MCAP was what I meant.

I guess the next update after 30 Sept will address that for everyone.

I have concerns that progress will have been to slow on the revenues front and costs will have continued to rise to support current company valuation..

Not asking you anything, just pointing out that an £18m MCAP looks high without some revenue growth which I am not really seeing. In the last report the FD highlighted the following:

At the date of this report, a number of factors make it difficult to predict anticipated product and other commercial revenue and associated cash receipts, or income from any partnership or outlicensing agreement that may provide additional funds. Accordingly, as explained in more detail in Note 2 to the interim financial statements, the Board has concluded (as it did in the annual reports for the years ended 30 September 2022 and 30 September 2023) that there continues to be a material uncertainty which may cast significant doubt on the Group's ability to continue as a going concern.

We plan to update shareholders on progress towards the Group's aims over the remainder of the year, including provision of order volumes for PSE and CiRT for the financial year, shortly after 30 September 2024.

From Shore Cap Note in June

For the future, the sheer size and opportunity of the PSE test once successfully commercialised is the key to supporting future financial independence of the company and the company achieves its 1000 tests per month objective. Inevitably, the increased activity generally with increased lab space and additional (more experienced) sales hires as OBD seeks to optimise its commercial business model has led to increased costs and an operating loss of £6.0m. We note that the company bolstered its cash resources by raising £9.9m gross in March 2024 and we look forward to the potential for the company to secure partners for the canine cancer (EpiSwitch SCB) and colorectal cancer (EpiSwitch NST) programmes which could boost cash resources.

With an MCAP of £18m, OBD has a lot to prove why/how that is valid?

All these posts from both sides add nothing to my knowledge of PPP, hundreds of commentaries and totally wasted.

As Jack says just wait for the company to update via RNS, everything else is pure speculation

Problem when you have a determined seller taking any old prices daily. Just not enough buyers to balance it off each day.

Another low today.

Fg

As a holder 300p would be off the scale for me. Is that genuinely doable from just one well. Seems a very big number v current mcap of £25m?

It is

Tricky,

Are you in at PPP?

Same at OBD (Oxford Bio Dynamics)...on line presentation, again investors expressed concerns about funding and placings in near term, CEO dismissed it and FD actually said not to worry, we have always raised monies at a premium...that was when the shares were 20p, a few months later a huge discounted placing hit the market, has never recovered.

DRM,

AVACTA was a classic, CEO even went on line in company presentations and said people had expressed concerns about funding and placements, he gave categoric guarantees investors had no need to worry about funding issues or potential discounted placings...that was at £1.50,,, placed shares at a huge discount within months

DrM,

Re AIM shares, same with me and several others I know...AIM has been going down the sh***er for years. Now its become a genuine casino where 90% of the market is day traders making bets only. Makes almost impossible to buy and hold anything, especially when they issue good news and get sold down because traders bail out to chase another stock almost the same day. I did ok on a few shares getting in early and 2 were declared AIM shares of the year in different years, both crashed and burned in the end and are no longer listed. Too many bent CEOs, NOMADS, Brokers all of them are on the take take take on AIM. If we get lucky we get something back but its getting harder and harder every month.

Tricky,

Hard enough making money without these amateur night day traders everywhere, becoming a joke